Kuzniewicz et al reported a modified Clinical Risk Index to evaluate neonate at risk for hyperbilirubinemia. This is based on the score of Newman et al. The authors are from the University of California San Francisco and Kaiser Permanente.
Patient selection: neonate >= 35 weeks of age with hyperbilirubinemia
Outcome: severe hyperbilirubinemia
Parameters:
(1) gestational age in weeks
(2) feeding
(3) neonatal jaundice requiring phototherapy in parent or sibling
(4) cephalohematoma or bruising
(5) race
(6) maternal age in years
(7) gender
Parameter |
Finding |
Points |
gestational age |
35 weeks |
12 |
|
36 weeks |
10 |
|
37 weeks |
7 |
|
38 weeks |
4 |
|
39 weeks |
2 |
|
40 weeks |
0 |
|
41 weeks |
-2 |
|
42 weeks |
-4 |
feeding |
breast milk only |
6 |
|
formula only |
-6 |
|
both |
0 |
neonatal jaundice in family member |
no |
0 |
|
yes |
6 |
cephalohematoma or bruising |
no |
0 |
|
yes |
4 |
race |
not Asian |
0 |
|
Asian |
4 |
maternal age |
< 25 years |
0 |
|
>= 25 years |
3 |
gender |
female |
0 |
|
male |
1 |
total score =
= SUM(points for all of the parameters)
Interpretation:
• minimum score: -10
• maximum score: 36
• The higher the score the greater the risk of hyperbilirubinemia.
Follow-up period is based on the score and the serum total bilirubin risk group o the Bhutani nomogram
Score |
Low Risk |
Low-Intermediate |
High-Intermediate |
High Risk |
< 5 |
NA |
NA |
1 to 3 days |
1 day |
5 to 9 |
NA |
1 to 3 days |
1 to 2 days |
1 day |
10 to 14 |
1 to 3 days |
1 to 2 days |
1 day |
1 day |
>= 15 |
1 to 2 days |
1 day |
1 day |
1 day |
Specialty: Pedatrics, Gastroenterology